Konstantinos Stavroulakis, Anders Wanhainen, Athanasios Thanos Saratzis
{"title":"Beyond Financial Conflicts of Interest in Vascular Practice.","authors":"Konstantinos Stavroulakis, Anders Wanhainen, Athanasios Thanos Saratzis","doi":"10.1016/j.ejvs.2026.10.026","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.026","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149289978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Changing Clinical Practice to Reduce Opioid Exposure after Vascular Surgery.","authors":"Jeppe K Petersen, Emil Fosbøl","doi":"10.1016/j.ejvs.2026.10.027","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.027","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149289993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Enrico Gallitto, Gustavo S Oderich, Tilo Kölbel, Stephan Haulon, Nikolas Tsilimparis, Nuno Dias, Andres Schanzer, Jonathan Sobocinski, Kevin Mani, Mauro Gargiulo
{"title":"Outcomes of Total Endovascular Repair of Aortic Arch and Thoraco-abdominal Aortic Aneurysms in the International Multicenter Aortic Research Group in a Selected Group of Patients with Extensive Aortic Aneurysm Disease.","authors":"Enrico Gallitto, Gustavo S Oderich, Tilo Kölbel, Stephan Haulon, Nikolas Tsilimparis, Nuno Dias, Andres Schanzer, Jonathan Sobocinski, Kevin Mani, Mauro Gargiulo","doi":"10.1016/j.ejvs.2026.10.019","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.019","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to report outcomes of total endovascular aortic repair (TEAR) using arch branched endovascular aortic repair (aBEVAR) and thoraco-abdominal aortic aneurysm (TAAA) fenestrated branched endovascular aortic repair (FBEVAR).</p><p><strong>Methods: </strong>Clinical data from 16 participating centres in the International Multicenter Aortic Research Group from 2014 to 2024 were retrospectively analysed. All patients who underwent TEAR were included. The primary outcome was aortic related mortality (ARM). Secondary outcomes included stroke and or transient ischaemic attack (TIA), spinal cord ischaemia (SCI), and freedom from target artery (TA) instability, re-interventions, and new cardiovascular events (CVEs) within 1 year.</p><p><strong>Results: </strong>Of 98 patients scheduled for TEAR, 95 (97%) completed both stages, including 46 (48%) with chronic post-dissection aneurysms and 49 (52%) with degenerative aneurysms. A multistage approach with aBEVAR followed by TAAA FBEVAR was used in all patients, with a median interval between stages of 11 months (interquartile range [IQR] 5, 14). One (1%) rupture occurred between the staged procedures (successfully managed with off the shelf TAAA multibranch stent graft). Custom made and off the shelf TAAA FBEVAR devices were used in 79 (83%) and 16 (17%) patients, respectively. There were 12 (13%) stroke and or TIAs (aBEVAR, ten; TAAA FBEVAR, two); five (5%) had a modified Rankin Scale score > 3. Sixteen patients (17%) experienced SCI (aBEVAR, two; TAAA FBEVAR, 14) with three cases (3%) of paraplegia. Four patients (4%) died within thirty days; these were the only cases of ARM. Median follow up was 32 months (IQR 3, 61). Of 67 patients (71%) with available one year follow up, there were six (9%) with TA instability and five (7%) CVEs. Estimated three year survival was 79 ± 5% with a cumulative incidence of re-intervention of 31 ± 6%.</p><p><strong>Conclusion: </strong>Multistage TEAR with aBEVAR followed by TAAA FBEVAR was associated with low ARM, re-intervention, and TA instability. Stroke and SCI remain significant and must be carefully weighed during patient selection and treatment.</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Can Patients with Ruptured Abdominal Aortic Aneurysm Go the Distance?","authors":"Matti Laine","doi":"10.1016/j.ejvs.2026.10.020","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.020","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Carotid Re-stenosis: When Narrowing Demands a Wider View.","authors":"Pirkka Vikatmaa, Athanasios Saratzis","doi":"10.1016/j.ejvs.2026.10.021","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.021","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Joseph M Czerniecki, Bjoern D Suckow, Alison W Henderson, Daniel C Norvell
{"title":"Effect of Microvascular Disease on Re-amputation Risk after Unilateral Amputation due to Diabetes or Peripheral Arterial Disease: A Retrospective Cohort Study.","authors":"Joseph M Czerniecki, Bjoern D Suckow, Alison W Henderson, Daniel C Norvell","doi":"10.1016/j.ejvs.2026.10.023","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.023","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to evaluate the association between manifestations of microvascular disease (MVD) and other factors on re-amputation risk within 12 months following incident unilateral lower extremity amputation.</p><p><strong>Methods: </strong>This was a retrospective cohort study of 8 924 patients with first unilateral transmetatarsal, transtibial, or transfemoral amputation secondary to diabetes and or peripheral arterial disease, identified through a Veterans Affairs database. Re-amputation was defined as any subsequent ipsilateral soft tissue or bony revision or amputation to a higher level. The presence of MVD was determined using a composite variable that required the involvement of each subcomponent (neuropathy, nephropathy, and retinopathy), and also by evaluating each of the subcomponent MVD variables separately. Twenty-nine additional risk factors were evaluated in relation to the primary outcome of re-amputation. A competing risk analysis estimated the cumulative incidence of re-amputation. The effect of risk factors on re-amputation risk was estimated by computing subdistribution hazard ratios (sub-HRs) with 95% confidence intervals (CIs).</p><p><strong>Results: </strong>The twelve month re-amputation risk was 38.0% (transmetatarsal), 27.2% (transtibial), and 14.1% (transfemoral). The combined MVD variable was not significantly associated with re-amputation risk. However, re-amputation after transmetatarsal amputation was significantly elevated in patients with retinopathy, leukocytosis, or those who were on kidney dialysis, with the highest risk in those with all three (sub-HR 2.2, 95% CI 1.8 - 2.6). Similarly, for transtibial patients, the risk was higher in the presence of retinopathy, leukocytosis, and kidney dialysis, and in those with a prior ipsilateral revascularisation and those on warfarin. The highest risk was observed in those with all factors present (sub-HR 2.1, 95% CI 1.6 - 2.7).</p><p><strong>Conclusion: </strong>This study identified an important association between the pre-amputation diagnosis of retinopathy and risk for subsequent failure of primary healing and need for re-amputation. Presence of retinopathy should be considered when evaluating potential failure of healing during amputation level decisions.</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247710","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Revisiting Cardiovascular Outcomes from Cilostazol: Promise and Caution.","authors":"Maria-Elisabeth Leinweber, Christopher P Twine","doi":"10.1016/j.ejvs.2026.10.024","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.024","url":null,"abstract":"","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Angelos Karelis, Giuseppe Asciutto, Magnus Jonsson, Sebastian Svarre, Robert Lind, Eric Jurgen Dorenberg, David McGeevy, Kevin Mani, Nuno V Dias, Timothy Resch
{"title":"Early Outcomes of Thoracic Branch Endoprosthesis in Aortic Arch Pathologies: A Nordic Multicentre Study.","authors":"Angelos Karelis, Giuseppe Asciutto, Magnus Jonsson, Sebastian Svarre, Robert Lind, Eric Jurgen Dorenberg, David McGeevy, Kevin Mani, Nuno V Dias, Timothy Resch","doi":"10.1016/j.ejvs.2026.10.017","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.017","url":null,"abstract":"<p><strong>Objective: </strong>This study evaluated the feasibility and early clinical outcomes of the Gore thoracic branch endoprosthesis (TBE) in the treatment of aortic arch pathologies.</p><p><strong>Methods: </strong>This multicentre retrospective study, conducted and reported in accordance with the STROBE statement, included consecutive patients undergoing thoracic endovascular aortic repair with TBE between February 2024 and July 2025. No restrictions were applied regarding the type or extent of aortic disease, use of staged procedures, or concomitant adjunctive endovascular interventions. Primary endpoints were technical success, thirty day mortality, and overall survival, while endoleak occurrence, primary target vessel patency, stroke, and spinal cord ischaemia (SCI) were secondary.</p><p><strong>Results: </strong>Sixty-four patients (median age 73 years [interquartile range 59, 77]; 69% men) were included. Indications for treatment included degenerative aneurysm (n = 26; 41%), chronic dissection (n = 18; 28%), subacute dissection (n = 11; 17%), and acute dissection (n = 9; 14%). The left subclavian artery was the target vessel in 59 cases (92%), followed by the brachiocephalic trunk in three (5%) and the left common carotid artery in two (3%). Technical success was achieved in 95% of cases (n = 61), with failures attributed to two type Ia endoleaks and one type IIIa endoleak. Thirty day mortality was 3% (n = 2). Early unplanned re-interventions occurred in four patients (6%). No strokes or SCI were observed. Median follow up was 6 months (2, 10). No late mortality was observed, and primary patency of all branches was 100%. One late unplanned re-intervention, unrelated to the TBE device, was required. During follow up, 12 patients (19%) had endoleaks, including type II (n = 4), type Ia (n = 4), type Ib (n = 2), type III (n = 1), and type V (n = 1). Estimated freedom from type Ia endoleak at 12 months was 93 ± 3%, while estimated overall survival at 12 months was 97 ± 2%.</p><p><strong>Conclusion: </strong>TBE demonstrated high technical success and acceptable early outcomes across a range of aortic arch pathologies. However, the relatively high rate of endoleaks and need for early re-interventions highlight the importance of careful patient selection and close continuous post-operative surveillance.</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Stijn B J Teijink, Reshabh Yadav, Yves Y Dujardin, Niels Pesser, Barend M E Mees, Saskia Houterman, Jens Goeteyn, Joep A W Teijink
{"title":"Long Term Results of Surgical Treatment of Chronic Venous Thoracic Outlet Syndrome: A Single Centre Experience.","authors":"Stijn B J Teijink, Reshabh Yadav, Yves Y Dujardin, Niels Pesser, Barend M E Mees, Saskia Houterman, Jens Goeteyn, Joep A W Teijink","doi":"10.1016/j.ejvs.2026.10.014","DOIUrl":"https://doi.org/10.1016/j.ejvs.2026.10.014","url":null,"abstract":"<p><strong>Objective: </strong>This retrospective cohort study with cross-sectional analysis aimed to evaluate the surgical and long term functional outcomes of a structured treatment algorithm for patients with chronic venous thoracic outlet syndrome (cVTOS).</p><p><strong>Methods: </strong>Patients with cVTOS and treated at this tertiary centre between 2016 and 2024 were included. Treatment consisted of transaxillary thoracic outlet decompression (TOD), venolysis, and subclavian vein (SCV) recanalisation. In case of persistent venous obstruction during the primary procedure, anticipated repeat percutaneous transluminal angioplasty (PTA) was planned. Anticoagulation (rivaroxaban) was prescribed until 48 hours before surgery, resumed the day after surgery for six weeks, or until 48 hours before re-PTA. The primary endpoint included SCV patency and secondary outcomes included functional outcomes (DASH and Derkash scores).</p><p><strong>Results: </strong>Seventy patients were included (mean age 35 years; 56% women). Median time to presentation was 40 (20.0 - 104.0) months after initial upper extremity deep vein thrombosis (UEDVT). Eleven patients (16%) had an operative complication (haematoma n = 6, pneumothorax n = 1, UEDVT n = 1, transient Horner syndrome n = 1, phrenic nerve injury n = 1, and SCV rupture n = 1). Median length of hospital stay was 1.0 day. Venography post-TOD/PTA showed persistent venous obstruction in 15 patients (21%) for which re-PTA was planned. Over time, 20 patients (29%) developed re-stenosis. A total of 35 (50%) re-PTAs were performed. Primary patency was 56%, primary assisted patency was 86%, and secondary patency was 93% at last follow up (12 months). Median post-operative DASH score decreased significantly (pre-op: 32.9 (15.8 - 48.3) vs. post-op 8.0 (2.3 - 27.8); p < .001) with a mean follow up of 45.7 ± 27.5 months. Zero patients reported a poor Derkash score.</p><p><strong>Conclusion: </strong>Chronic VTOS can be effectively treated with good long term functional outcomes. Re-PTAs were necessary in half of the cases (anticipated). This treatment algorithm diminished the need of secondary interventions in 50% of the cases, as well as the need for long term anticoagulation usage.</p>","PeriodicalId":55160,"journal":{"name":"European Journal of Vascular and Endovascular Surgery","volume":" ","pages":""},"PeriodicalIF":8.5,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149208013","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}